Epigral Limited (EPIGRAL) — Board Meeting | 27 July 2026 (2 announcements)

Epigral Limited announced board approval to establish a new epoxy resin and formulations multi-purpose plant at Dahej, Gujarat, with an estimated investment of ₹600 crores targeting 1,25,000 TPA capacity by H2 FY2028, funded through a mix of debt and internal accruals to expand its product portfolio and capture growing demand.

Epigral Limited announced the outcome of its board meeting held on July 27, 2026, approving unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The unaudited standalone results show revenue of ₹705.36 crores, profit after tax of ₹99.18 crores, and EPS of ₹22.99. The consolidated results report profit after tax of ₹99.74 crores and EPS of ₹23.12. The board also approved the incorporation of a wholly owned subsidiary, Epigral Advanced Material Limited, on July 7, 2026, to focus on chemical manufacturing. The company reaffirmed its tax optimization strategy under Section 115BAA and highlighted ongoing investments in Prozeal Green Power entities for renewable energy projects.